Communication Bridge ™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia

DiscussionThe CB2 trial will supply Level 2 evidence regarding the efficacy of the Communication Bridge ™ intervention delivered in a telehealth service delivery model for individuals with mild to moderate PPA. An important by-product of the CB2 trial is that these data can be used to evaluate the efficacy of speech-language interventions delivered in both trial arms for persons with PPA. The impact of these data should not be overlooked as they will yield important insights examining why interventions work and for whom, which will advance effectiveness trials for speech-language interventions in PPA.Trial RegistrationClinicalTrials.govNCT03371706. Registered prospectively on December 13, 2017.
Source: Trials - Category: Research Source Type: clinical trials